terodiline has been researched along with verapamil in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (18.18) | 18.7374 |
| 1990's | 2 (18.18) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Du, LP; Li, MY; Tsai, KC; Xia, L; You, QD | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Sen, S; Sinha, N | 1 |
| Brown, AM; Bruening-Wright, A; Kramer, J; Kuryshev, YA; Myatt, G; Obejero-Paz, CA; Verducci, JS | 1 |
| Ekström, B | 1 |
| Arrhenius, E; Larsson-Backström, C; Sagge, K | 1 |
| Baker, JE; Hearse, DJ | 1 |
| Kaneko, S; Nakano, D; Nishimori, T; Ohara, M | 1 |
| Avery, MJ; DePasquale, MJ; Fossa, AA; Leishman, DJ; Raunig, DL | 1 |
11 other study(ies) available for terodiline and verapamil
| Article | Year |
|---|---|
The pharmacophore hypotheses of I(Kr) potassium channel blockers: novel class III antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Models, Biological; Models, Molecular; Potassium Channel Blockers; Potassium Channels; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
MICE models: superior to the HERG model in predicting Torsade de Pointes.
Topics: ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Humans; Models, Theoretical; Patch-Clamp Techniques; Predictive Value of Tests; Torsades de Pointes | 2013 |
Intravesical instillation of drugs in patients with detrusor hyperactivity.
Topics: Administration, Intravesical; Animals; Atropine; Butylamines; Female; Humans; Parasympatholytics; Phentolamine; Rabbits; Urinary Bladder; Urinary Bladder, Neurogenic; Urodynamics; Verapamil | 1992 |
Comparison of the calcium-antagonistic effects of terodiline, nifedipine and verapamil.
Topics: Acetylcholine; Animals; Butylamines; Calcium Channel Blockers; Dose-Response Relationship, Drug; In Vitro Techniques; Nifedipine; Norepinephrine; Potassium; Rabbits; Rats; Stereoisomerism; Swine; Vasoconstriction; Verapamil | 1985 |
Slow calcium channel blockers and the calcium paradox: comparative studies in the rat with seven drugs.
Topics: Animals; Butylamines; Calcium; Calcium Channel Blockers; Diltiazem; Dose-Response Relationship, Drug; Fendiline; Gallopamil; In Vitro Techniques; Ion Channels; Male; Myocardium; Nifedipine; Prenylamine; Rats; Verapamil | 1983 |
[Effects of propiverine hydrochloride (propiverine) on isolated rat and dog urinary bladder].
Topics: Acetylcholine; Animals; Atropine; Benzilates; Butylamines; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Female; In Vitro Techniques; Male; Mandelic Acids; Muscarinic Antagonists; Muscle Contraction; Parasympatholytics; Potassium Chloride; Propantheline; Rats; Rats, Wistar; Urinary Bladder; Urination; Urination Disorders; Vasodilator Agents; Verapamil | 1999 |
The relationship of clinical QT prolongation to outcome in the conscious dog using a beat-to-beat QT-RR interval assessment.
Topics: Animals; Anti-Arrhythmia Agents; Butylamines; Cisapride; Disease Models, Animal; Dogs; Female; Heart Rate; Long QT Syndrome; Male; Piperidines; Pyridines; Terfenadine; Verapamil | 2002 |